Terms: = Ovarian cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
22 results:
1. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
2. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
3. Primary ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
Chen X; Liu HL; Wang JS; Zhao FH
Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
[TBL] [Abstract] [Full Text] [Related]
4. Screening and Identification of a Prognostic Model of ovarian cancer by Combination of Transcriptomic and Proteomic Data.
Jiang J; Chen Z; Wang H; Wang Y; Zheng J; Guo Y; Jiang Y; Mo Z
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189432
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of immature ovarian teratomas through single-cell transcriptome.
Cao M; Deng Y; Deng Y; Wu J; Yang C; Wang Z; Hou Q; Fu H; Ren Z; Xia X; Li Y; Wang W; Xu H; Liao X; Shu Y
Front Immunol; 2023; 14():1131814. PubMed ID: 36936909
[TBL] [Abstract] [Full Text] [Related]
6. The value of sox2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
[TBL] [Abstract] [Full Text] [Related]
7. In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and sox2.
du Manoir S; Delpech H; Orsetti B; Jacot W; Pirot N; Noel J; Colombo PE; Sardet C; Theillet C
J Pathol; 2022 Jul; 257(3):367-378. PubMed ID: 35302657
[TBL] [Abstract] [Full Text] [Related]
8. Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of ovarian High-Grade Serous Carcinoma.
Matsumoto T; Oda Y; Hasegawa Y; Hashimura M; Oguri Y; Inoue H; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M
Am J Pathol; 2021 Oct; 191(10):1837-1850. PubMed ID: 34214505
[TBL] [Abstract] [Full Text] [Related]
9. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
10. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.
Kusumoto S; Kurashige M; Ohshima K; Tahara S; Matsui T; Nojima S; Hattori S; Morii E
Cancer Med; 2021 Mar; 10(5):1485-1500. PubMed ID: 33611864
[TBL] [Abstract] [Full Text] [Related]
11. Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer.
Connor EV; Saygin C; Braley C; Wiechert AC; Karunanithi S; Crean-Tate K; Abdul-Karim FW; Michener CM; Rose PG; Lathia JD; Reizes O
J Ovarian Res; 2019 Nov; 12(1):112. PubMed ID: 31735168
[TBL] [Abstract] [Full Text] [Related]
12. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.
Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Akiya M; Saegusa M
Mol Carcinog; 2018 Aug; 57(8):957-967. PubMed ID: 29603383
[TBL] [Abstract] [Full Text] [Related]
13. RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
Somasagara RR; Spencer SM; Tripathi K; Clark DW; Mani C; Madeira da Silva L; Scalici J; Kothayer H; Westwell AD; Rocconi RP; Palle K
Oncogene; 2017 Nov; 36(48):6680-6690. PubMed ID: 28806395
[TBL] [Abstract] [Full Text] [Related]
14. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.
Liu J; Wang L; Wang Y; Zhang W; Cao Y
PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690
[TBL] [Abstract] [Full Text] [Related]
15. sox2 is required to maintain cancer stem cells in ovarian cancer.
Wen Y; Hou Y; Huang Z; Cai J; Wang Z
Cancer Sci; 2017 Apr; 108(4):719-731. PubMed ID: 28165651
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
Chebouti I; Blassl C; Wimberger P; Neubauer H; Fehm T; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 May; 7(18):26454-64. PubMed ID: 27049920
[TBL] [Abstract] [Full Text] [Related]
17. Establishment and Characterization of an In Vitro Model of ovarian cancer Stem-like Cells with an Enhanced Proliferative Capacity.
Ishiguro T; Sato A; Ohata H; Ikarashi Y; Takahashi RU; Ochiya T; Yoshida M; Tsuda H; Onda T; Kato T; Kasamatsu T; Enomoto T; Tanaka K; Nakagama H; Okamoto K
Cancer Res; 2016 Jan; 76(1):150-60. PubMed ID: 26669863
[TBL] [Abstract] [Full Text] [Related]
18. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases.
Liang L; Zhang Y; Malpica A; Ramalingam P; Euscher ED; Fuller GN; Liu J
Mod Pathol; 2015 Dec; 28(12):1613-20. PubMed ID: 26564007
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of sox2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway.
Li Y; Chen K; Li L; Li R; Zhang J; Ren W
Tumour Biol; 2015 Dec; 36(12):9823-8. PubMed ID: 26159849
[TBL] [Abstract] [Full Text] [Related]
20. sox2 expression and prognostic significance in ovarian carcinoma.
Pham DL; Scheble V; Bareiss P; Fischer A; Beschorner C; Adam A; Bachmann C; Neubauer H; Boesmueller H; Kanz L; Wallwiener D; Fend F; Lengerke C; Perner S; Fehm T; Staebler A
Int J Gynecol Pathol; 2013 Jul; 32(4):358-67. PubMed ID: 23722508
[TBL] [Abstract] [Full Text] [Related]
[Next]
